Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03246815
Other study ID # PRO14110416
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 12, 2017
Est. completion date December 30, 2020

Study information

Verified date March 2021
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

National guidelines have recommended routine STD screening (chlamydia and gonorrhea) for sexually active young women under the age of 25. Despite these recommendations, many young women are not being screened for STDs, with some estimates that less than 50% of women receiving health care are screened for chlamydia. Untreated STDs can lead to important sequelae to women's reproductive health including pelvic inflammatory disease, infertility and ectopic pregnancy. One of the most important barriers to widespread STD screening is provider failure to recognize an opportunity for STD screening. The goal of this study is to determine whether offering STD screening (chlamydia and gonorrhea) by a non-physician member of the medical practice (who receives an automated alert indicating STD screening should be offered) will be associated with a higher rate of STD screening in young women attending primary care practices compared to usual care (where a physician offers screening with no electronic alert). This study will be performed in UPMC-affiliated primary care practices (Family Practice, Internal Medicine, OB/GYN, Pediatrics). Practices will be assigned to the intervention or usual care. The intervention will be an auto-task in the electronic medical record to the non-physician/NP/PA medical staff (medical assistants, LPNs, RNs) to offer chlamydia and gonorrhea screening via urine or self-collected vaginal sampling, in an opt-out manner, to eligible women. Practices assigned to the usual care group will not have the intervention. STD screening rates (# women undergoing STD screening/# eligible women) will be compared between the to groups (intervention practices and control practices). Results of this study may be important to guide national STD screening recommendations and will address critical barriers to widespread STD screening.


Recruitment information / eligibility

Status Completed
Enrollment 6771
Est. completion date December 30, 2020
Est. primary completion date November 11, 2019
Accepts healthy volunteers
Gender Female
Age group 15 Years to 24 Years
Eligibility Inclusion Criteria: Women ages 15-24 Sexually Active Receiving care in one of the primary care offices affiliated with UPMC selected for this study. Exclusion Criteria: Pregnancy

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Magee-Womens Hospital of UPMC/associated community clinics Pittsburgh Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
University of Pittsburgh CDC Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of STD Screening Rate of screening (Chlamydia and Gonorrhea) in young women attending primary care practices Day 1
Primary Number of Chlamydia and Gonorrhea infections identified Day 1
See also
  Status Clinical Trial Phase
Completed NCT01084421 - A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos N/A
Completed NCT04079608 - Rigorous Evaluation of High School FLASH N/A
Completed NCT05674682 - Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study N/A
Terminated NCT04156516 - Longitudinal Effects of a Sexual Health Intervention: HEART N/A
Active, not recruiting NCT05161689 - Addressing the Continuum of Care Among High-risk Thai Men N/A
Recruiting NCT03486522 - STD Screening in Women Admitted in Family Planning for a Termination of Pregnancy
Completed NCT00994019 - Study of Oral Papillomavirus In Teens and Twenties